6821 - 6830 of 7730 Results
Title
Year
- The BioFIND Study (Fox Investigation For New Discovery Of Biomarkers In Parkinson’s Disease): Design And Methodology (P4.043)2014RESTRICTEDTitle: The BioFIND Study (Fox Investigation For New Discovery Of Biomarkers In Parkinson’s Disease): Design And Methodology (P4.043)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 82Issue #: 10_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.82.10_supplement.p4.043Citation Count: 2
-
RESTRICTEDTitle: Evaluation of mild cognitive impairment subtypes in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 756End Page: 764Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25875Best OA location URL: https://europepmc.org/articles/pmc4013249?pdf=renderCitation Count: 54
-
RESTRICTEDTitle: Treating Parkinson's disease in the 21st century: Can stem cell transplantation compete?Journal Name: Journal of Comparative NeurologyPublisher: WileyVol: 522Issue #: 12Start Page: 2802End Page: 2816Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/cne.23577Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cne.23577Citation Count: 46
- Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficits2014RESTRICTEDTitle: Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficitsJournal Name: Frontiers in Systems NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnsys.2014.00045Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnsys.2014.00045/pdfCitation Count: 85
- Accelerating Drug Development for the Field: Building Clinical Trial Recruitment Infrastructure in Parkinson’s2014RESTRICTEDTitle: Accelerating Drug Development for the Field: Building Clinical Trial Recruitment Infrastructure in Parkinson’sJournal Name:Publisher:Vol:Issue #:Start Page: 22End Page: 27Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.14524/cr-13-00066r1.1Citation Count: 1
- Attentional resource allocation and swallowing safety in Parkinson's disease: A dual task study2014RESTRICTEDTitle: Attentional resource allocation and swallowing safety in Parkinson's disease: A dual task studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 4Start Page: 439End Page: 443Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2013.12.011Best OA location URL: https://europepmc.org/articles/pmc4646094?pdf=renderCitation Count: 40
- Can Isolated Enlarged Virchow-Robin Spaces Influence the Clinical Manifestations of Parkinson's Disease?2014RESTRICTEDTitle: Can Isolated Enlarged Virchow-Robin Spaces Influence the Clinical Manifestations of Parkinson's Disease?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 1Start Page: 67End Page: 69Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12009Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12009Citation Count: 15
- Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP Cohort2014RESTRICTEDTitle: Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP CohortJournal Name: The American Journal of PathologyPublisher: Elsevier BVVol: 184Issue #: 4Start Page: 966End Page: 975Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ajpath.2013.12.007Best OA location URL: http://ajp.amjpathol.org/article/S0002944014000121/pdfCitation Count: 121
- Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s disease2014RESTRICTEDTitle: Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s diseaseJournal Name: NeurosciencePublisher: Elsevier BVVol: 265Issue #:Start Page: 245End Page: 252Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2014.01.042Citation Count: 34
- Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease2014RESTRICTEDTitle: Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 64Issue #:Start Page: 79End Page: 87Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2013.12.011Best OA location URL: https://doi.org/10.1016/j.nbd.2013.12.011Citation Count: 70